Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 3
2013 1
2014 2
2015 1
2016 3
2017 2
2018 2
2019 2
2020 7
2021 12
2022 10
2023 5
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
A Machine Learning Algorithm Facilitates Prognosis Prediction and Treatment Selection for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma.
Han JW, Lee SK, Kwon JH, Nam SW, Yang H, Bae SH, Kim JH, Nam H, Kim CW, Lee HL, Kim HY, Lee SW, Lee A, Chang UI, Song DS, Kim SH, Song MJ, Sung PS, Choi JY, Yoon SK, Jang JW. Han JW, et al. Among authors: lee sk. Clin Cancer Res. 2024 Apr 19. doi: 10.1158/1078-0432.CCR-23-3978. Online ahead of print. Clin Cancer Res. 2024. PMID: 38639918
Differential liver function at cessation of atezolizumab-bevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative study.
Han JW, Sung PS, Yoo JS, Cho HS, Lee SK, Yang H, Kim JH, Nam H, Lee HL, Kim HY, Lee SW, Song DS, Song MJ, Kwon JH, Kim CW, Bae SH, Jang JW, Choi JY, Yoon SK. Han JW, et al. Among authors: lee sk. Front Oncol. 2024 Feb 28;14:1372007. doi: 10.3389/fonc.2024.1372007. eCollection 2024. Front Oncol. 2024. PMID: 38482199 Free PMC article.
Machine learning-based clinical decision support system for treatment recommendation and overall survival prediction of hepatocellular carcinoma: a multi-center study.
Lee KH, Choi GH, Yun J, Choi J, Goh MJ, Sinn DH, Jin YJ, Kim MA, Yu SJ, Jang S, Lee SK, Jang JW, Lee JS, Kim DY, Cho YY, Kim HJ, Kim S, Kim JH, Kim N, Kim KM. Lee KH, et al. Among authors: lee sk. NPJ Digit Med. 2024 Jan 5;7(1):2. doi: 10.1038/s41746-023-00976-8. NPJ Digit Med. 2024. PMID: 38182886 Free PMC article.
A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis.
Lee SK, Kwon JH, Lee SW, Lee HL, Kim HY, Kim CW, Song DS, Chang UI, Yang JM, Nam SW, Kim SH, Song MJ, Kim JH, Lee A, Yang H, Bae SH, Han JW, Nam H, Sung PS, Jang JW, Choi JY, Yoon SK, Shim DJ, Kim D, Kim M. Lee SK, et al. Cancers (Basel). 2023 Sep 4;15(17):4423. doi: 10.3390/cancers15174423. Cancers (Basel). 2023. PMID: 37686699 Free PMC article.
Chemoembolization combined radiofrequency ablation vs. chemoembolization alone for treatment of beyond the Milan criteria viable hepatocellular carcinoma (CERFA): study protocol for a randomized controlled trial.
Lee SK, Yang H, Kwon JH, Shim DJ, Kim D, Nam SW, Yoo SH, Bae SH, Lee A, Lee YJ, Jeon C, Jang JW, Sung PS, Chun HJ, Kim SH, Choi JI, Oh JS, Yang YJ. Lee SK, et al. Trials. 2023 Mar 28;24(1):234. doi: 10.1186/s13063-023-07266-4. Trials. 2023. PMID: 36978150 Free PMC article.
53 results